Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF.
Voordes G, Davison B, Biegus J, Edwards C, Damman K, Ter Maaten J, Mebazaa A, Takagi K, Adamo M, Ambrosy AP, Arrigo M, Barros M, Celutkiene J, Čerlinskaitė-Bajorė K, Chioncel O, Cohen-Solal A, Damasceno A, Deniau B, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Metra M, Novosadova M, Pagnesi M, Pang P, Ponikowski P, Saidu H, Sliwa K, Tomasoni D, Cotter G, Voors AA.
Voordes G, et al.
Eur J Heart Fail. 2024 Jul;26(7):1480-1492. doi: 10.1002/ejhf.3336. Epub 2024 Jun 14.
Eur J Heart Fail. 2024.
PMID: 38874185
Clinical Trial.